Pharma channel feed – Endpoints News

Pharma channel feed

Lilly meets sales expectations, but Novo gains on PBM win

4 weeks ago

Amicus grabs Dimerix’s rare kidney disease drug for $30M upfront

4 weeks ago

Moderna expands effort to rein in costs in an ‘uncertain environment’

4 weeks ago

BeiGene scores a win from US Patent Office in spat over Brukinsa

4 weeks ago

Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments

4 weeks ago

FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB

4 weeks ago

Updated: Novartis to buy Regulus Therapeutics for up to $1.7B

4 weeks ago

GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says

4 weeks ago

BridgeBio’s Attruby outperforms sales expectations, shares rise

4 weeks ago

Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies

4 weeks ago

Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’

4 weeks ago

FDA approves Abeona’s skin disease cell therapy

4 weeks ago

With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership

4 weeks ago

Hims and Novo Nordisk partner to offer discounted Wegovy

4 weeks ago

AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near

4 weeks ago

Pfizer launches a new wave of cost cuts, expects $7.7B in total savings through 2027

4 weeks ago

AstraZeneca posts another Truqap study fail, says China import tax could triple

4 weeks ago

Novartis continues earnings winning streak as it raises 2025 sales expectations

4 weeks ago

Vaxart says it can resume next-gen Covid work, will screen participants for oral vaccine trial

4 weeks ago

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

4 weeks ago

WuXi AppTec sees growth after 2024 dip, plans ‘lean’ operations to temper ‘external opportunities’

4 weeks ago

Daiichi Sankyo says production boost in US will help cushion tariff impact

4 weeks ago

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

4 weeks ago

European regulators recommend new drugs from Vertex, Amgen and Jazz

4 weeks ago

First page Previous page 2 3 456 7 8 Next page Last page